Sending Office: Honorable Bobby L. Rush
Supported by: National Medical Association
Cosponsors (59): Adams, Barragán, Bass, Beatty, Sanford D. Bishop Jr., Blunt Rochester, Bonamici, Brown, Butterfield, Carson, Clarke, Clay, Clyburn, Cohen, Courtney, Danny K. Davis, Demings, Dingell, Evans, Fudge, Jesús G. “Chuy” García,
Grijalva, Hastings, Hayes, Horsford, Eddie Bernice Johnson, Henry C. “Hank” Johnson Jr., Robin L. Kelly, Khanna, Krishnamoorthi, Lawson, Barbara Lee, Jackson Lee, Lewis, McEachin, Moore, Morelle, Neguse, Norton, Payne, Plaskett, Pressley, Raskin, Richmond,
Roybal-Allard, Ruppersberger, Schakowsky, David Scott, Robert C. “Bobby” Scott, Serrano, Sewell, Sires, Slotkin, Soto, Bennie G. Thompson, Tlaib, Watson Coleman, Wild, Frederica S. Wilson
Access to insulin can improve — and even save — countless lives. That’s why in 1921, the scientists who isolated insulin sold the patent for this procedure to the University of Toronto for $3, and for decades, insulin was affordable for those who relied
A century later, skyrocketing costs are leading not only to extreme financial hardship for some of the most vulnerable Americans, but numerous untimely deaths due to insulin rationing. Alec Smith could not afford his $1,300 monthly medical bills. He died
27 days after losing his health insurance at the age of 26.
Unfortunately, Alec is one of many. According to the Centers for Disease Control, over 100 million Americans have diabetes or pre-diabetes, and Black, Hispanic, and American Indian/Alaskan Native populations are more likely to be living with diabetes than
White and Asian populations. A study by The Lancet Diabetes & Endocrinology journal predicts that by 2030, 79 million adults with type 2 diabetes are expected to need insulin to manage their condition. If current levels of access remain, only half
of them will be able to get an adequate supply.
That is why I have introduced
H.R. 366, the Insulin Access for All Act. This bill eliminates the cost-sharing requirement — including deductibles, copayments, and coinsurances — for insulin under both Medicare and Medicaid.
Diabetes is an epidemic, and we must ensure access to affordable medication for this disease.
I invite you to join me in cosponsoring the Insulin Access for All Act. To learn more or to cosponsor, please contact Lauren Citron in my office at
Lauren.Citron@mail.house.gov or 5-4372.
Bobby L. Rush
Member of Congress
e-Dear Colleague version 2.0